Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein

Annals of Neurology

Volumn 44, Issue 3, 1998, Pages 415-422

  Tu, Pang Hsien ^a   Galvin, James E ^a,b   Baba, Minami ^c   Giasson, Benoit ^a   Tomita, Taisuke ^c   Leight, Susan ^a   Nakajo, Shigeo ^d   Iwatsubo, Takeshi ^c   Trojanowski, John Q ^a   Lee, Virginia M Y ^a,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CELL INCLUSION; CLINICAL ARTICLE; FEMALE; GLIA CELL; HUMAN; LEWY BODY; MALE; NERVE DEGENERATION; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SOLUBILITY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANTIBODIES; FEMALE; GAMMA-SYNUCLEIN; HUMANS; INCLUSION BODIES; MALE; MICROFILAMENTS; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEUROGLIA; OLIGODENDROGLIA; SOLUBILITY; SYNUCLEINS;

EID: 0031713491     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440324     Document Type: Article

References (43)

1. Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Gen 1998;18:106-108
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
3. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-884
4. Irrizary MC, Growdon W, Gomez-Isla T, et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998;57:334-337
5. Spillantini MG, Crowther RA, Jakes R, et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469-6473
6. Spillantini MG, Schmidt ML, Lee VM, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-840
7. Takeda A, Mallory M, Sundsmo M, et al. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 1998;152:367-372
8. Wakabayashi K, Matsumoto K, Takayama K, et al. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 1997;239:45-48
9. Maroteaux L, Campanelli JT, Scheller RH. Synuclein is a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 1988;8:2804-2815
10. Maroteaux L, Scheller RH. The rat brain synucleins: a family of proteins transiently associated with neuronal membrane. Mol Brain Res 1991;11:335-343
11. Uéda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-11286
12. Iwai A, Masliah E, Yoshimoto M, Ge N, et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14:467-475
13. Jensen PH, Hojrup P, Hager H, et al. Binding of Aβ to α-and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC. Biochem J 1997;323:539-546
14. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-32
15. Spillantini MG, Divane A, Goedert M. Assignment of human α-synuclein (SNCA) and β-synuclein (SNCB) genes to chromosomes 4q21 and 5q35. Genomics 1995;27:379-381
16. Ji H, Liu YE, Jia T, et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 1997;57:759-764
17. Nakajo S, Omata K, Aiuchi T, et al. Purification and characterization of a novel brain-specific 14-kd protein. J Neurochem 1990;55:2031-2038
18. Nakajo S, Tsukada K, Kameyama H, et al. Distribution of phosphoneuroprotein 14 (PNP14) in vertebrates: its levels as determined by enzyme immunoassay. Brain Res 1996;741: 180-184
19. Nakajo S, Tsukada K, Omata K, et al. A new brain-specific 14-kd protein protein is a phosphoprotein: its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 1993;217:1057-1063
20. Shibayama-Imazu T, Okahashi I, Omata K, et al. Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res 1993; 622:17-25
21. George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the Zebra finch. Neuron 1995;15:361-372
22. Goedert M. The awakening of α-synuclein. Nature 1997;388: 232-233
23. Irizarry MC, Kim T-W, McNamara M, et al. Characterization of the precursor protein of the non-Aβ component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 1996;55:889-895
24. Trojanowski JQ, Lee VM-Y. Aggregation of neurofilament and α-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson's disease and Lewy body dementia. Arch Neuroi 1998;55:151-152
25. Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Movement Disord 1997;12:133-147
26. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neuroi Sci 1989;9:79-100
27. Arai N, Nishimura M, Oda M, et al. Immunohistochemical expression of microtubule-associated protein 5 (MAP5) in glial cells in multiple system atrophy. J Neurol Sci 1992;109:102-106
28. Cairns NJ, Atkinson PF, Hanger DP, et al. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett 1997;230:49-52
29. Tamaoka A, Mizusawa H, Mori H, Shoji S. Ubiquitinated alpha B-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy. J Neurol Sci 1995; 129:192-198
30. Schmidt ML, Murray J, Lee VM-Y, et al. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991;139:53-65
31. Tu PH, Robinson KA, de Snoo F, et al. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice. J Neurosci 1997;17:1064-1074
32. Vonsattel JP, Aizawa H, Ge P, et al. An improved approacch to prepare human brains for research. J Neuropathol Exp Neurol 1995;54:42-56
33. Dalchau R, Kirkley J, Fabre JW. Monoclonal antibody to a human leukocyte specific membrane glycoprotein probably homologous to the leukocyte common (LC) antigen of the rat. Eur J Immunol 1980;10:737-744
34. Kim SU, McMorris FA, Sprinkle TJ. Immunofluorescence demonstration of 2′-3′ cyclic nucleotide 3′-phosphodiesterase in cultured oligodendrocytes of mouse, rat, calf and human. Brain Res 1984;300:195-199
35. Lee VM-Y, Page CD, Wu H-L, Schlaepfer WW. Monoclonal antibodies to gel-excised glial filament protein and their reactivities with other intermediate filament proteins. J Neurochem 42:25-32
36. Chin SS-M, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathal Exp Neurol 1996;55:499-508
37. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol 1996;40:139-148
38. Goedert M, Trojanowski JQ, Lee VM-Y. The neurofibrillary pathology of Alzheimer's disease. In: Prusiner SB, Rosenberg RN, DiMauro S, Barchi RL, eds. The molecular and genetic basis of neurological disease. 2nd ed. New York: Butterworth-Heinemann, 1997:613-627
39. Trojanowski JQ, Goedert M, Iwatsubo T, et al. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Diff 1998 (in press)
40. Galvin JE, Lee VMY, Baba M, et al. Monoclonal antibodies to purified cortical Lewy bodies recognize the midsize neurofilament subunit. Ann Neurol 1997;42:595-603
41. Goldman JE, Yen SH, Chiu FC, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983;221:1082-1084
42. Hill WD, Lee VMY, Hurtig HI, et al. Epitopes located in spatially separate domains of each neurofilament subunit are present in the Lewy bodies of Parkinson's disease. J Comp Neurol 1991;109:150-160
43. Spillantini MG, Goedert M, Crowther RA, et al. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Nad Acad Sci USA 1997;94:4113-4118